These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Advancing Chelation Chemistry for Actinium and Other +3 f-Elements, Am, Cm, and La. Stein BW; Morgenstern A; Batista ER; Birnbaum ER; Bone SE; Cary SK; Ferrier MG; John KD; Pacheco JL; Kozimor SA; Mocko V; Scott BL; Yang P J Am Chem Soc; 2019 Dec; 141(49):19404-19414. PubMed ID: 31794205 [TBL] [Abstract][Full Text] [Related]
11. Optimization of Cation Exchange for the Separation of Actinium-225 from Radioactive Thorium, Radium-223 and Other Metals. Fitzsimmons J; Foley B; Torre B; Wilken M; Cutler CS; Mausner L; Medvedev D Molecules; 2019 May; 24(10):. PubMed ID: 31109077 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes. Wilson JJ; Ferrier M; Radchenko V; Maassen JR; Engle JW; Batista ER; Martin RL; Nortier FM; Fassbender ME; John KD; Birnbaum ER Nucl Med Biol; 2015 May; 42(5):428-438. PubMed ID: 25684650 [TBL] [Abstract][Full Text] [Related]
13. The coordination chemistry of Cm Ferrier MG; Stein BW; Bone SE; Cary SK; Ditter AS; Kozimor SA; Lezama Pacheco JS; Mocko V; Seidler GT Chem Sci; 2018 Sep; 9(35):7078-7090. PubMed ID: 30310628 [TBL] [Abstract][Full Text] [Related]
14. Detailed Chemistry Studies of Eryilmaz K; Kilbas B Curr Radiopharm; 2022; 15(1):76-83. PubMed ID: 34053430 [TBL] [Abstract][Full Text] [Related]
15. A review of recent advancements in Actinium-225 labeled compounds and biomolecules for therapeutic purposes. Hassan M; Bokhari TH; Lodhi NA; Khosa MK; Usman M Chem Biol Drug Des; 2023 Nov; 102(5):1276-1292. PubMed ID: 37715360 [TBL] [Abstract][Full Text] [Related]
16. Radiometric evaluation of diglycolamide resins for the chromatographic separation of actinium from fission product lanthanides. Radchenko V; Mastren T; Meyer CAL; Ivanov AS; Bryantsev VS; Copping R; Denton D; Engle JW; Griswold JR; Murphy K; Wilson JJ; Owens A; Wyant L; Birnbaum ER; Fitzsimmons J; Medvedev D; Cutler CS; Mausner LF; Nortier MF; John KD; Mirzadeh S; Fassbender ME Talanta; 2017 Dec; 175():318-324. PubMed ID: 28841997 [TBL] [Abstract][Full Text] [Related]
17. Development of Robertson AKH; Ramogida CF; Schaffer P; Radchenko V Curr Radiopharm; 2018; 11(3):156-172. PubMed ID: 29658444 [TBL] [Abstract][Full Text] [Related]
18. Construction of a thorium/actinium generator at the Canadian Nuclear Laboratories. Perron R; Gendron D; Causey PW Appl Radiat Isot; 2020 Oct; 164():109262. PubMed ID: 32819503 [TBL] [Abstract][Full Text] [Related]
19. Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody. Schwartz J; Jaggi JS; O'Donoghue JA; Ruan S; McDevitt M; Larson SM; Scheinberg DA; Humm JL Phys Med Biol; 2011 Feb; 56(3):721-33. PubMed ID: 21220845 [TBL] [Abstract][Full Text] [Related]
20. An Eighteen-Membered Macrocyclic Ligand for Actinium-225 Targeted Alpha Therapy. Thiele NA; Brown V; Kelly JM; Amor-Coarasa A; Jermilova U; MacMillan SN; Nikolopoulou A; Ponnala S; Ramogida CF; Robertson AKH; Rodríguez-Rodríguez C; Schaffer P; Williams C; Babich JW; Radchenko V; Wilson JJ Angew Chem Int Ed Engl; 2017 Nov; 56(46):14712-14717. PubMed ID: 28963750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]